S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61

Dolby Laboratories Stock Forecast, Price & News

+2.67 (+3.64%)
(As of 06/24/2022 06:40 PM ET)
Today's Range
50-Day Range
52-Week Range
518,400 shs
Average Volume
537,825 shs
Market Capitalization
$7.67 billion
P/E Ratio
Dividend Yield
Price Target
30 days | 90 days | 365 days | Advanced Chart

Receive DLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.

DLB Stock Forecast (MarketRank)

Overall MarketRank

2.81 out of 5 stars

Consumer Discretionary Sector

56th out of 397 stocks

Patent Owners & Lessors Industry

3rd out of 12 stocks

Analyst Opinion: 2.5Community Rank: 3.9Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -
Dolby Laboratories logo

About Dolby Laboratories (NYSE:DLB)

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

DLB Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Patent owners & lessors
Electronic Components
Year Founded

Company Calendar

Last Earnings
Ex-Dividend for 5/25 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
$310.23 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.28 billion
Cash Flow
$4.28 per share
Book Value
$25.74 per share


Free Float
Market Cap
$7.67 billion

Social Links

Dolby Laboratories Frequently Asked Questions

Should I buy or sell Dolby Laboratories stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Dolby Laboratories stock.
View analyst ratings for Dolby Laboratories
or view top-rated stocks.

What is Dolby Laboratories' stock price forecast for 2022?

3 brokerages have issued 12-month target prices for Dolby Laboratories' stock. Their DLB stock forecasts range from $90.00 to $90.00. On average, they predict Dolby Laboratories' share price to reach $90.00 in the next twelve months. This suggests a possible upside of 18.4% from the stock's current price.
View analysts' price targets for Dolby Laboratories
or view top-rated stocks among Wall Street analysts.

How has Dolby Laboratories' stock price performed in 2022?

Dolby Laboratories' stock was trading at $95.22 on January 1st, 2022. Since then, DLB shares have decreased by 20.2% and is now trading at $76.00.
View the best growth stocks for 2022 here

Are investors shorting Dolby Laboratories?

Dolby Laboratories saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,440,000 shares, an increase of 54.2% from the April 30th total of 933,600 shares. Based on an average daily volume of 550,700 shares, the days-to-cover ratio is currently 2.6 days. Approximately 2.3% of the company's stock are short sold.
View Dolby Laboratories' Short Interest

When is Dolby Laboratories' next earnings date?

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Dolby Laboratories

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories, Inc. (NYSE:DLB) released its earnings results on Thursday, May, 5th. The electronics maker reported $0.70 earnings per share for the quarter, beating analysts' consensus estimates of $0.60 by $0.10. The electronics maker had revenue of $334.37 million for the quarter, compared to the consensus estimate of $332.51 million. Dolby Laboratories had a net margin of 17.14% and a trailing twelve-month return on equity of 9.72%. The firm's revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.73 earnings per share.
View Dolby Laboratories' earnings history

How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?

Dolby Laboratories announced a quarterly dividend on Friday, May 6th. Stockholders of record on Tuesday, May 17th will be given a dividend of $0.25 per share on Wednesday, May 25th. This represents a $1.00 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Monday, May 16th.
View Dolby Laboratories' dividend history

Is Dolby Laboratories a good dividend stock?

Dolby Laboratories(NYSE:DLB) pays an annual dividend of $1.00 per share and currently has a dividend yield of 1.32%. Dolby Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Dolby Laboratories is 48.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 32.26% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.
View Dolby Laboratories' dividend history.

What guidance has Dolby Laboratories issued on next quarter's earnings?

Dolby Laboratories updated its third quarter 2022 earnings guidance on Monday, May, 30th. The company provided EPS guidance of $0.54-$0.69 for the period, compared to the consensus earnings per share estimate of $1.02. The company issued revenue guidance of $285.00 million-$310.00 million, compared to the consensus revenue estimate of $340.25 million.

Who are Dolby Laboratories' key executives?

Dolby Laboratories' management team includes the following people:

What is Kevin J. Yeaman's approval rating as Dolby Laboratories' CEO?

253 employees have rated Dolby Laboratories CEO Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among Dolby Laboratories' employees.

Who are some of Dolby Laboratories' key competitors?

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Rogers (ROG) and Vishay Intertechnology (VSH).
View all of DLB's competitors

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

What is Dolby Laboratories' stock symbol?

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (6.15%), Clearbridge Investments LLC (3.26%), BlackRock Inc. (3.07%), Ninety One UK Ltd (2.70%), Bank of New York Mellon Corp (1.75%) and Disciplined Growth Investors Inc. MN (1.52%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Dagmar Dolby, Ed H Bowman Jr, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories

Which major investors are selling Dolby Laboratories stock?

DLB stock was sold by a variety of institutional investors in the last quarter, including Polar Capital Holdings Plc, Ceredex Value Advisors LLC, BlackRock Inc., Prudential Financial Inc., Mackenzie Financial Corp, AEGON ASSET MANAGEMENT UK Plc, Sumitomo Mitsui Trust Holdings Inc., and Trinity Street Asset Management LLP. Company insiders that have sold Dolby Laboratories company stock in the last two years include Avadis Tevanian, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories
or view top insider-selling stocks.

Which major investors are buying Dolby Laboratories stock?

DLB stock was bought by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Ninety One UK Ltd, First Trust Advisors LP, Bank of New York Mellon Corp, UBS Group AG, NewEdge Wealth LLC, Vanguard Group Inc., and Bank of America Corp DE.
View insider buying and selling activity for Dolby Laboratories
or or view top insider-buying stocks.

How do I buy shares of Dolby Laboratories?

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dolby Laboratories' stock price today?

One share of DLB stock can currently be purchased for approximately $76.00.

How much money does Dolby Laboratories make?

Dolby Laboratories (NYSE:DLB) has a market capitalization of $7.67 billion and generates $1.28 billion in revenue each year. The electronics maker earns $310.23 million in net income (profit) each year or $2.069990 on an earnings per share basis.

How many employees does Dolby Laboratories have?

Dolby Laboratories employs 2,368 workers across the globe.

Does Dolby Laboratories have any subsidiaries?

The following companies are subsidiares of Dolby Laboratories: Coding Technologies, Dolby International AB, Dolby Laboratories Licensing Corporation, Doremi Labs, Step Labs, and Voxeet.
Read More

When was Dolby Laboratories founded?

Dolby Laboratories was founded in 1965.

How can I contact Dolby Laboratories?

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for Dolby Laboratories is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at [email protected], or via fax at 415-645-4000.

This page (NYSE:DLB) was last updated on 6/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.